• mail us help@24marketresearch.com
  • Int'l (+1)-646-781-7170
  • UK(Toll free) +44-800-088-5734

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Macular Edema Therapeutics Market Size, Status and Forecast 2018-2025

Global Macular Edema Therapeutics Market Size, Status and Forecast 2018-2025

  • Category:Life Sciences
  • Published on : 29 August 2018
  • Pages :100
  • Formats:
  • Report Code:24MRES-3055700
Click for best price

Best Price: $3120

This report focuses on the global Macular Edema Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Macular Edema Therapeutics development in United States, Europe and China.

Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).
The market of macular edema is dominated by North America which is followed by Europe due tremendous number of population suffering from diabetics. Asia Pacific region have also shown faster rate of increases of macular edema therapeutics market. While Africa and Australia have low market of Macular edema. In Asia pacific region India, China and Brazil have shown emerging growth in the global market of macular edema therapeutics.
In 2017, the global Macular Edema Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Allergan
Novartis
Roche
Regeneron Pharmaceuticals
Pfizer
Bayer
Boehringer Ingelheim
Bausch & Lomb
Aciont
ActiveSite Pharmaceuticals
Adverum Biotechnologies
Aerpio Therapeutics
Ampio Pharmaceuticals
Araim Pharmaceuticals
Astellas Pharma

Market segment by Type, the product can be split into
Laser Treatment
Anti-VEGF Injection
Anti-Inflammatory Treatment
Vitrectomy

Market segment by Application, split into
Cystoid Macular Edema (CME)
Diabetic Macular Edema(DME)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Macular Edema Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Macular Edema Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Macular Edema Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENTS

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Macular Edema Therapeutics Market Size Growth Rate by Type (2013-2025)
1.4.2 Laser Treatment
1.4.3 Anti-VEGF Injection
1.4.4 Anti-Inflammatory Treatment
1.4.5 Vitrectomy
1.5 Market by Application
1.5.1 Global Macular Edema Therapeutics Market Share by Application (2013-2025)
1.5.2 Cystoid Macular Edema (CME)
1.5.3 Diabetic Macular Edema(DME)
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Macular Edema Therapeutics Market Size
2.2 Macular Edema Therapeutics Growth Trends by Regions
2.2.1 Macular Edema Therapeutics Market Size by Regions (2013-2025)
2.2.2 Macular Edema Therapeutics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Macular Edema Therapeutics Market Size by Manufacturers
3.1.1 Global Macular Edema Therapeutics Revenue by Manufacturers (2013-2018)
3.1.2 Global Macular Edema Therapeutics Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Macular Edema Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Macular Edema Therapeutics Key Players Head office and Area Served
3.3 Key Players Macular Edema Therapeutics Product/Solution/Service
3.4 Date of Enter into Macular Edema Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Macular Edema Therapeutics Market Size by Type (2013-2018)
4.2 Global Macular Edema Therapeutics Market Size by Application (2013-2018)

5 United States
5.1 United States Macular Edema Therapeutics Market Size (2013-2018)
5.2 Macular Edema Therapeutics Key Players in United States
5.3 United States Macular Edema Therapeutics Market Size by Type
5.4 United States Macular Edema Therapeutics Market Size by Application

6 Europe
6.1 Europe Macular Edema Therapeutics Market Size (2013-2018)
6.2 Macular Edema Therapeutics Key Players in Europe
6.3 Europe Macular Edema Therapeutics Market Size by Type
6.4 Europe Macular Edema Therapeutics Market Size by Application

7 China
7.1 China Macular Edema Therapeutics Market Size (2013-2018)
7.2 Macular Edema Therapeutics Key Players in China
7.3 China Macular Edema Therapeutics Market Size by Type
7.4 China Macular Edema Therapeutics Market Size by Application

8 Japan
8.1 Japan Macular Edema Therapeutics Market Size (2013-2018)
8.2 Macular Edema Therapeutics Key Players in Japan
8.3 Japan Macular Edema Therapeutics Market Size by Type
8.4 Japan Macular Edema Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Macular Edema Therapeutics Market Size (2013-2018)
9.2 Macular Edema Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Macular Edema Therapeutics Market Size by Type
9.4 Southeast Asia Macular Edema Therapeutics Market Size by Application

10 India
10.1 India Macular Edema Therapeutics Market Size (2013-2018)
10.2 Macular Edema Therapeutics Key Players in India
10.3 India Macular Edema Therapeutics Market Size by Type
10.4 India Macular Edema Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Macular Edema Therapeutics Market Size (2013-2018)
11.2 Macular Edema Therapeutics Key Players in Central & South America
11.3 Central & South America Macular Edema Therapeutics Market Size by Type
11.4 Central & South America Macular Edema Therapeutics Market Size by Application

12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Macular Edema Therapeutics Introduction
12.1.4 Allergan Revenue in Macular Edema Therapeutics Business (2013-2018)
12.1.5 Allergan Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Macular Edema Therapeutics Introduction
12.2.4 Novartis Revenue in Macular Edema Therapeutics Business (2013-2018)
12.2.5 Novartis Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Macular Edema Therapeutics Introduction
12.3.4 Roche Revenue in Macular Edema Therapeutics Business (2013-2018)
12.3.5 Roche Recent Development
12.4 Regeneron Pharmaceuticals
12.4.1 Regeneron Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Macular Edema Therapeutics Introduction
12.4.4 Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2013-2018)
12.4.5 Regeneron Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Macular Edema Therapeutics Introduction
12.5.4 Pfizer Revenue in Macular Edema Therapeutics Business (2013-2018)
12.5.5 Pfizer Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Macular Edema Therapeutics Introduction
12.6.4 Bayer Revenue in Macular Edema Therapeutics Business (2013-2018)
12.6.5 Bayer Recent Development
12.7 Boehringer Ingelheim
12.7.1 Boehringer Ingelheim Company Details
12.7.2 Company Description and Business Overview
12.7.3 Macular Edema Therapeutics Introduction
12.7.4 Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2013-2018)
12.7.5 Boehringer Ingelheim Recent Development
12.8 Bausch & Lomb
12.8.1 Bausch & Lomb Company Details
12.8.2 Company Description and Business Overview
12.8.3 Macular Edema Therapeutics Introduction
12.8.4 Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2013-2018)
12.8.5 Bausch & Lomb Recent Development
12.9 Aciont
12.9.1 Aciont Company Details
12.9.2 Company Description and Business Overview
12.9.3 Macular Edema Therapeutics Introduction
12.9.4 Aciont Revenue in Macular Edema Therapeutics Business (2013-2018)
12.9.5 Aciont Recent Development
12.10 ActiveSite Pharmaceuticals
12.10.1 ActiveSite Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Macular Edema Therapeutics Introduction
12.10.4 ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2013-2018)
12.10.5 ActiveSite Pharmaceuticals Recent Development
12.11 Adverum Biotechnologies
12.12 Aerpio Therapeutics
12.13 Ampio Pharmaceuticals
12.14 Araim Pharmaceuticals
12.15 Astellas Pharma

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES & FIGURES

List of Tables and Figures

Table Macular Edema Therapeutics Key Market Segments
Table Key Players Macular Edema Therapeutics Covered
Table Global Macular Edema Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Macular Edema Therapeutics Market Size Market Share by Type 2013-2025
Figure Laser Treatment Figures
Table Key Players of Laser Treatment
Figure Anti-VEGF Injection Figures
Table Key Players of Anti-VEGF Injection
Figure Anti-Inflammatory Treatment Figures
Table Key Players of Anti-Inflammatory Treatment
Figure Vitrectomy Figures
Table Key Players of Vitrectomy
Table Global Macular Edema Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
Figure Cystoid Macular Edema (CME) Case Studies
Figure Diabetic Macular Edema(DME) Case Studies
Figure Macular Edema Therapeutics Report Years Considered
Table Global Macular Edema Therapeutics Market Size 2013-2025 (Million US$)
Figure Global Macular Edema Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Macular Edema Therapeutics Market Size by Regions 2013-2025 (Million US$)
Table Global Macular Edema Therapeutics Market Size by Regions 2013-2018 (Million US$)
Table Global Macular Edema Therapeutics Market Share by Regions 2013-2018
Figure Global Macular Edema Therapeutics Market Share by Regions 2013-2018
Figure Global Macular Edema Therapeutics Market Share by Regions 2018
Table Market Top Trends
Table Global Macular Edema Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Macular Edema Therapeutics Market Share by Manufacturers (2013-2018)
Figure Global Macular Edema Therapeutics Market Share by Manufacturers in 2018
Table Global Macular Edema Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Macular Edema Therapeutics Product/Solution/Service
Table Date of Enter into Macular Edema Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Macular Edema Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Global Macular Edema Therapeutics Market Size Share by Type (2013-2018)
Figure Global Macular Edema Therapeutics Market Size Market Share by Type (2013-2018)
Table Global Macular Edema Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Global Macular Edema Therapeutics Market Size Share by Application (2013-2018)
Figure Global Macular Edema Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Macular Edema Therapeutics Revenue Market Share by Application in 2017
Figure United States Macular Edema Therapeutics Market Size 2013-2018 (Million US$)
Table United States Key Players Macular Edema Therapeutics Revenue (2017-2018) (Million US$)
Table United States Key Players Macular Edema Therapeutics Market Share (2017-2018)
Table United States Macular Edema Therapeutics Market Size by Type (2013-2018) (Million US$)
Table United States Macular Edema Therapeutics Market Share by Type (2013-2018)
Table United States Macular Edema Therapeutics Market Size by Application (2013-2018) (Million US$)
Table United States Macular Edema Therapeutics Market Share by Application (2013-2018)
Figure Europe Macular Edema Therapeutics Market Size 2013-2018 (Million US$)
Table Europe Key Players Macular Edema Therapeutics Revenue (2017-2018) (Million US$)
Table Europe Key Players Macular Edema Therapeutics Market Share (2017-2018)
Table Europe Macular Edema Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Europe Macular Edema Therapeutics Market Share by Type (2013-2018)
Table Europe Macular Edema Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Europe Macular Edema Therapeutics Market Share by Application (2013-2018)
Figure China Macular Edema Therapeutics Market Size 2013-2018 (Million US$)
Table China Key Players Macular Edema Therapeutics Revenue (2017-2018) (Million US$)
Table China Key Players Macular Edema Therapeutics Market Share (2017-2018)
Table China Macular Edema Therapeutics Market Size by Type (2013-2018) (Million US$)
Table China Macular Edema Therapeutics Market Share by Type (2013-2018)
Table China Macular Edema Therapeutics Market Size by Application (2013-2018) (Million US$)
Table China Macular Edema Therapeutics Market Share by Application (2013-2018)
Figure Japan Macular Edema Therapeutics Market Size 2013-2018 (Million US$)
Table Japan Key Players Macular Edema Therapeutics Revenue (2017-2018) (Million US$)
Table Japan Key Players Macular Edema Therapeutics Market Share (2017-2018)
Table Japan Macular Edema Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Japan Macular Edema Therapeutics Market Share by Type (2013-2018)
Table Japan Macular Edema Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Japan Macular Edema Therapeutics Market Share by Application (2013-2018)
Figure Southeast Asia Macular Edema Therapeutics Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Macular Edema Therapeutics Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Macular Edema Therapeutics Market Share (2017-2018)
Table Southeast Asia Macular Edema Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Macular Edema Therapeutics Market Share by Type (2013-2018)
Table Southeast Asia Macular Edema Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Macular Edema Therapeutics Market Share by Application (2013-2018)
Figure India Macular Edema Therapeutics Market Size 2013-2018 (Million US$)
Table India Key Players Macular Edema Therapeutics Revenue (2017-2018) (Million US$)
Table India Key Players Macular Edema Therapeutics Market Share (2017-2018)
Table India Macular Edema Therapeutics Market Size by Type (2013-2018) (Million US$)
Table India Macular Edema Therapeutics Market Share by Type (2013-2018)
Table India Macular Edema Therapeutics Market Size by Application (2013-2018) (Million US$)
Table India Macular Edema Therapeutics Market Share by Application (2013-2018)
Figure Central & South America Macular Edema Therapeutics Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Macular Edema Therapeutics Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Macular Edema Therapeutics Market Share (2017-2018)
Table Central & South America Macular Edema Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Central & South America Macular Edema Therapeutics Market Share by Type (2013-2018)
Table Central & South America Macular Edema Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Central & South America Macular Edema Therapeutics Market Share by Application (2013-2018)
Table Allergan Company Details
Table Allergan Revenue in Macular Edema Therapeutics Business (2013-2018) (Million US$)
Figure Allergan Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table Allergan Recent Development
Table Novartis Company Details
Table Novartis Revenue in Macular Edema Therapeutics Business (2013-2018)(Million US$)
Figure Novartis Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table Novartis Recent Development
Table Roche Company Details
Table Roche Revenue in Macular Edema Therapeutics Business (2013-2018)(Million US$)
Figure Roche Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table Roche Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2013-2018)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table Regeneron Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Macular Edema Therapeutics Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Macular Edema Therapeutics Business (2013-2018)(Million US$)
Figure Bayer Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table Bayer Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2013-2018)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table Boehringer Ingelheim Recent Development
Table Bausch & Lomb Company Details
Table Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2013-2018)(Million US$)
Figure Bausch & Lomb Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table Bausch & Lomb Recent Development
Table Aciont Company Details
Table Aciont Revenue in Macular Edema Therapeutics Business (2013-2018)(Million US$)
Figure Aciont Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table Aciont Recent Development
Table ActiveSite Pharmaceuticals Company Details
Table ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2013-2018)(Million US$)
Figure ActiveSite Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2013-2018)
Table ActiveSite Pharmaceuticals Recent Development
Table Adverum Biotechnologies Company Details
Table Aerpio Therapeutics Company Details
Table Ampio Pharmaceuticals Company Details
Table Araim Pharmaceuticals Company Details
Table Astellas Pharma Company Details
Table Global Macular Edema Therapeutics Market Size by Regions (Million US$) 2018-2025
Figure Global Macular Edema Therapeutics Market Size Share by Regions (2018-2025)
Figure Global Macular Edema Therapeutics Market Size Share by Regions in 2025
Figure United States Macular Edema Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Europe Macular Edema Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure China Macular Edema Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Japan Macular Edema Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Macular Edema Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure India Macular Edema Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Macular Edema Therapeutics Market Size Forecast (2018-2025)(Million USD)
Table Global Macular Edema Therapeutics Market Size by Product (2018-2025) (Million US$)
Figure Global Macular Edema Therapeutics Market Size by Product (2018-2025)
Figure Global Macular Edema Therapeutics Market Size by Product in 2025
Table Global Macular Edema Therapeutics Market Size by Application (2018-2025) (Million US$)
Figure Global Macular Edema Therapeutics Market Size by Application (2018-2025)
Figure Global Macular Edema Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SELECT A FORMAT

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount